AJ

Amol Jijabapu Gagare

Active Director Director DIN 11738864
DIN 11738864 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Amol Jijabapu Gagare

Data last updated:

Amol Jijabapu Gagare is a Director at Spg Lifesciences Private Limited (since 2026).

DIN 11738864
Primary Designation Director
First Appointment 26 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Spg Lifesciences Private Limited U46497PN2026PTC256185
Director26 May 20262026Active

Directorship timeline

Open interactive timeline →
Spg Lifesciences Private Limited
Premium access

Shareholding and investment profile for Amol Jijabapu Gagare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amol Jijabapu Gagare

Amol Jijabapu Gagare currently holds 1 directorship: Spg Lifesciences Private Limited (Director, since 26 May 2026).

Amol Jijabapu Gagare was first appointed on 26 May 2026 as Director at Spg Lifesciences Private Limited.

The current boards of Amol Jijabapu Gagare's companies include Gaurav Rajkumar Gandhi (Spg Lifesciences Private Limited), Navnath Ramchandra Kanawade (Spg Lifesciences Private Limited), Nilima Chetankumar Kardile (Spg Lifesciences Private Limited), Pratiksha Gaurav Gandhi (Spg Lifesciences Private Limited), Sarita Amol Gagare (Spg Lifesciences Private Limited), Sarthak Navnath Kanawade (Spg Lifesciences Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available